about
Preliminary results of the combination of bevacizumab and weekly Paclitaxel in advanced melanoma.Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis.Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patientsImproving disease control in advanced colorectal cancer: Panitumumab and cetuximab.Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancerPrognostic factors and prevention of radioembolization-induced liver disease.Liver disease induced by radioembolization of liver tumors: description and possible risk factors.
P50
Q33379895-66B6E4BD-7F55-49DC-8837-4FB5E4D4E27AQ33747440-C1292BF5-CCDC-4F2F-9DB7-D4C34F8736C7Q34343973-70E9246D-218E-4A1C-873C-582FBDBF8D63Q37584842-5A800928-7084-44DF-90E8-8B23859B46E0Q41096010-AEDE8F4D-41EF-4097-A479-B53B3E97141CQ45850436-F31A94A5-74CB-4D94-929B-0A98901339F4Q47925759-4BA354CF-FDAB-4960-A727-CE3047C7320C
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-0300-9433
@en
name
A Chopitea
@ast
A Chopitea
@en
A Chopitea
@nl
type
label
A Chopitea
@ast
A Chopitea
@en
A Chopitea
@nl
prefLabel
A Chopitea
@ast
A Chopitea
@en
A Chopitea
@nl
P106
P31
P496
0000-0003-0300-9433